Evidence of increased activation underlying cognitive control in ecstasy and cannabis users

NeuroImage

Volumn 52, Issue 2, 2010, Pages 429-435

  Roberts, Gloria M P ^a   Garavan, Hugh ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Ecstasy; FMRI; GO NOGO; Impulsivity; IVE; Response inhibition

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; CANNABINOID; OXYGEN; PSYCHEDELIC AGENT;

ADULT; ARTICLE; BRAIN REGION; CINGULATE GYRUS; COGNITION; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSIVENESS; MALE; MONITORING; NEUROIMAGING; PARIETAL LOBE; PRIORITY JOURNAL; PSYCHOMETRY; TASK PERFORMANCE; ADDICTION; BLOOD; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; CANNABIS ADDICTION; DRUG EFFECTS; EXECUTIVE FUNCTION; INHIBITION (PSYCHOLOGY); NERVE TRACT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; VASCULARIZATION; YOUNG ADULT;

BRAIN; BRAIN MAPPING; CANNABINOIDS; CEREBROVASCULAR CIRCULATION; COGNITION; EXECUTIVE FUNCTION; FEMALE; HALLUCINOGENS; HUMANS; INHIBITION (PSYCHOLOGY); MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 77953704780     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.04.192     Document Type: Article

References (89)

1. Aron A.R., Poldrack R.A. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J. Neurosci. 2006, 26:2424-2433.
2. Beats B.C., Sahakian B.J., Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol. Med. 1996, 26:591-603.
3. Berman S.M., Kuczenski R., McCracken J.T., London E.D. Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol. Psychiatry 2009, 14(2). Feb; Electronic publication 2008 Aug 12.
4. Braet W., Johnson K.A., Tobin C.T., Acheson R., Bellgrove M.A., Robertson I.H., Garavan H. Functional developmental changes underlying response inhibition and error-detection processes. Neuropsychologia 2009, 47:3143-3151.
5. Braver T.S., Barch D.M., Gray J.R., Molfese D.L., Snyder A. Anterior cingulate cortex and response conflict: effects of frequency, inhibition and errors. Cereb. Cortex 2001, 11:825-836.
6. Brody A.L., Mandelkern M.A., Olmstead R.E., Jou J., Tiongson E., Allen V., Scheibal D., London E.D., Monterosso J.R., Tiffany S.T., Korb A., Gan J.J., Cohen M.S. Neural substrates of resisting craving during cigarette cue exposure. Biol. Psychiatry 2007, 62:642-651.
7. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: anatomy, function, and relevance to disease. Ann. N. Y. Acad. Sci. 2008, 1124:1-38.
8. Butler G.K., Montgomery A.M. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend. 2004, 76:55-62.
9. Chamberlain S.R., Sahakian B.J. The neuropsychiatry of impulsivity. Curr. Opin. Psychiatry 2007, 20:255-261.
10. Chambers C.D., Bellgrove M.A., Stokes M.G., Henderson T.R., Garavan H., Robertson I.H., Morris A.P., Mattingley J.B. Executive "brake failure" following deactivation of human frontal lobe. J. Cogn. Neurosci. 2006, 18:444-455.
11. Clark L., Roiser J.P., Robbins T.W., Sahakian B.J. Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users. J. Psychopharmacol. 2008.
12. Clarke H.F., Dalley J.W., Crofts H.S., Robbins T.W., Roberts A.C. Cognitive inflexibility after prefrontal serotonin depletion. Science 2004, 304:878-880.
13. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 1996, 29:162-173.
14. Cropley V.L., Fujita M., Innis R.B., Nathan P.J. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol. Psychiatry 2006, 59:898-907.
15. Dafters R.I. Impulsivity, inhibition and negative priming in ecstasy users. Addict. Behav. 2006, 31:1436-1441.
16. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
17. Daumann J., Pelz S., Becker S., Tuchtenhagen F., Gouzoulis-Mayfrank E. Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum. Psychopharmacol. 2001, 16:627-633.
18. Douglas K.S., Guy L.S., Edens J.F., Boer D.P., Hamilton J. The Personality Assessment Inventory as a proxy for the Psychopathy Checklist Revised: testing the incremental validity and cross-sample robustness of the Antisocial Features Scale. Assessment 2007, 14:255-269.
19. Eagle D.M., Lehmann O., Theobald D.E., Pena Y., Zakaria R., Ghosh R., Dalley J.W., Robbins T.W. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 2009, 34:1311-1321.
20. Egan G., Silk T., Zamarripa F., Williams J., Federico P., Cunnington R., Carabott L., Blair-West J., Shade R., McKinley M., Farrell M., Lancaster J., Jackson G., Fox P., Denton D. Neural correlates of the emergence of consciousness of thirst. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15241-15246.
21. Elliott R., Sahakian B.J., Herrod J.J., Robbins T.W., Paykel E.S. Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment. J. Neurol. Neurosurg. Psychiatry 1997, 63:74-82.
22. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl) 1999, 146:348-361.
23. Eysench H.J., Eysench S.G.B. Adult Impulsiveness, Venturesomness, and Empathy Scale 1991, Hodder & Stoughton, LTD, London, UK.
24. Fischer C., Hatzidimitriou G., Wlos J., Katz J., Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). J. Neurosci. 1995, 15:5476-5485.
25. Fox H.C., McLean A., Turner J.J., Parrott A.C., Rogers R., Sahakian B.J. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology (Berl) 2002, 162:203-214.
26. Franklin T.R., Wang Z., Wang J., Sciortino N., Harper D., Li Y., Ehrman R., Kampman K., O'Brien C.P., Detre J.A., Childress A.R. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 2007, 32:2301-2309.
27. Fu L.P., Bi G.H., Zou Z.T., Wang Y., Ye E.M., Ma L., Ming F., Yang Z. Impaired response inhibition function in abstinent heroin dependents: an fMRI study. Neurosci. Lett. 2008, 438:322-326.
28. Garavan H., Stout J.C. Neurocognitive insights into substance abuse. Trends in Cognitive Sciences 2005, 9:195-201.
29. Garavan H., Ross T.J., Stein E.A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc. Natl Acad. Sci. USA 1999, 96:8301-8306.
30. Garavan H., Ross T.J., Murphy K., Roche R.A., Stein E.A. Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction. Neuroimage 2002, 17:1820-1829.
31. Garavan H., Hester R., Murphy K., Fassbender C., Kelly C. Individual differences in the functional neuroanatomy of inhibitory control. Brain Res. 2006, 1105:130-142.
32. Gerbing D.W., Ahadi S.A., Patton J.H. Toward a conceptualization of impulsivity: components across the behavioral and self-report domains. Multivariate Behav. Res. 1987, 357-379.
33. Gerra G., Zaimovic A., Ferri M., Zambelli U., Timpano M., Neri E., Marzocchi G.F., Delsignore R., Brambilla F. Long-lasting effects of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans. Biol. Psychiatry 2000, 47:127-136.
34. Gouzoulis-Mayfrank E., Thimm B., Rezk M., Hensen G., Daumann J. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:819-827.
35. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc. Natl Acad. Sci. USA 2003, 100:253-258.
36. Gudelsky G.A., Yamamoto B.K. Actions of 3, 4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 2008, 90:198-207.
37. Hanson K.L., Luciana M., Sullwold K. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend. 2008, 96:99-110.
38. Hatzidimitriou G., McCann U.D., Ricaurte G.A. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3, 4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J. Neurosci. 1999, 19:5096-5107.
39. Hester R., Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J. Neurosci. 2004, 24:11017-11022.
40. Hester R., Fassbender C., Garavan H. Individual differences in error processing: a review and reanalysis of three event-related fMRI studies using the GO/NOGO task. Cereb. Cortex 2004, 14:986-994.
41. Hester R., Nestor L., Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in current cannabis users. Neuropsychopharmacology 2009, 34:2450-2458.
42. Hoshi R., Cohen L., Lemanski L., Piccini P., Bond A., Curran H.V. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls. Exp. Clin. Psychopharmacol. 2007, 15:351-358.
43. Jocham G., Ullsperger M. Neuropharmacology of performance monitoring. Neurosci. Biobehav. Rev. 2009, 33:48-60.
44. Kaufman J.N., Ross T.J., Stein E.A., Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J. Neurosci. 2003, 23:7839-7843.
45. Kiehl K.A., Liddle P.F., Hopfinger J.B. Error processing and the rostral anterior cingulate: an event-related fMRI study. Psychophysiology 2000, 37:216-223.
46. Klein T.A., Neumann J., Reuter M., Hennig J., von Cramon D.Y., Ullsperger M. Genetically determined differences in learning from errors. Science 2007, 318:1642-1645.
47. Konishi S., Nakajima K., Uchida I., Kikyo H., Kameyama M., Miyashita Y. Common inhibitory mechanism in human inferior prefrontal cortex revealed by event-related functional MRI. Brain 1999, 122(Pt 5):981-991.
48. Lerner A., Bagic A., Hanakawa T., Boudreau E.A., Pagan F., Mari Z., Bara-Jimenez W., Aksu M., Sato S., Murphy D.L., Hallett M. Involvement of insula and cingulate cortices in control and suppression of natural urges. Cereb. Cortex 2009, 19:218-223.
49. Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., Mzengeza S., Young S.N., Blier P., Benkelfat C. Brain Regional alpha-[11C]methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 2001, 158:775-782.
50. Li C.S., Huang C., Constable R.T., Sinha R. Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing. J. Neurosci. 2006, 26:186-192.
51. Liddle P.F., Kiehl K.A., Smith A.M. Event-related fMRI study of response inhibition. Hum. Brain Mapp. 2001, 12:100-109.
52. Lijffijt M., Bekker E.M., Quik E.H., Bakker J., Kenemans J.L., Verbaten M.N. Differences between low and high trait impulsivity are not associated with differences in inhibitory motor control. J. Atten. Disord. 2004, 8:25-32.
53. Liu Y.P., Wilkinson L.S., et al. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. Psychopharmacology (Berl) 2004, 173(1-2):175-185.
54. Lynch W.J., Roth M.E., Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berl) 2002, 164:121-137.
55. Malle B.F., Neubauer A.C. Impulsivity, reflection, and questionnaire response latencies: no evidence for a broad impulsivity trait. Individ. Differ. 1991, 865-871.
56. McCann U.D., Ridenour A., Shaham Y., Ricaurte G.A. Serotonin neurotoxicity after (+/-)3, 4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans. Neuropsychopharmacology 1994, 10:129-138.
57. McKiernan K.A., Kaufman J.N., Kucera-Thompson J., Binder J.R. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 2003, 15:394-408.
58. Menon V., White C.D., Eliez S., Glover G.H., Reiss A.L. Analysis of a distributed neural system involved in spatial information, novelty, and memory processing. Hum. Brain Mapp. 2000, 11:117-129.
59. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. Am. J. Psychiatry 2001, 158:1783-1793.
60. Moeller F.G., Steinberg J.L., et al. Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl) 2004, 177(1-2):185-194.
61. Morgan M.J. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998, 19:252-264.
62. Morgan M.J., McFie L., Fleetwood H., Robinson J.A. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?. Psychopharmacology (Berl) 2002, 159:294-303.
63. Morgan M.J., Impallomeni L.C., Pirona A., Rogers R.D. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 2006, 31:1562-1573.
64. Murphy K., Garavan H. Artifactual fMRI group and condition differences driven by performance confounds. Neuroimage 2004, 21:219-228.
65. Murphy K., Garavan H. Deriving the optimal number of events for an event-related fMRI study based on the spatial extent of activation. Neuroimage 2005, 27:771-777.
66. Murphy F.C., Michael A., Robbins T.W., Sahakian B.J. Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance. Psychol. Med. 2003, 33:455-467.
67. Nielson K.A., Langenecker S.A., Garavan H. Differences in the functional neuroanatomy of inhibitory control across the adult life span. Psychol. Aging 2002, 17:56-71.
68. Nutt D., King L.A., Saulsbury W., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007, 369:1047-1053.
69. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 1988, 8:2788-2803.
70. Parrott A.C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 1998, 139:261-268.
71. Parrott A.C., Sisk E., Turner J.J. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug Alcohol Depend. 2000, 60:105-110.
72. Paulus M.P., Tapert S.F., Schuckit M.A. Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse. Arch. Gen. Psychiatry 2005, 62:761-768.
73. Pruessmann K.P., Weiger M., Scheidegger M.B., Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn. Reson. Med. 1999, 42:952-962.
74. Quednow B.B., Kuhn K.U., Hoppe C., Westheide J., Maier W., Daum I., Wagner M. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl) 2007, 189:517-530.
75. Reneman L., Majoie C.B., Habraken J.B., den Heeten G.J. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology 2001, 220:611-617.
76. Reynolds B., Ortengren A., Richards J.B., de Wit H. Dimensions of impulsive behaviour: personality and behavioural measures. Pers. Individ. Differ. 2006, 305.
77. Risch S.C., Nemeroff C.B. Neurochemical alterations of serotonergic neuronal systems in depression. J. Clin. Psychiatry 1992, 53(Suppl, 3-7).
78. Small D.M., Zatorre R.J., Dagher A., Evans A.C., Jones-Gotman M. Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 2001, 124:1720-1733.
79. Soubrie P. Serotonergic neurons and behavior. J. Pharmacol. 1986, 17:107-112.
80. Talairach J., Tournoux P. C0-planar Stereotaxic Atlas of the Human Brain 1998, Thieme, New York.
81. Tarter R.E., Kirisci L., Mezzich A., Cornelius J.R., Pajer K., Vanyukov M., Gardner W., Blackson T., Clark D. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am. J. Psychiatry 2003, 160:1078-1085.
82. Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999, 55:105-115.
83. Tuchtenhagen F., Daumann J., Norra C., Gobbele R., Becker S., Pelz S., Sass H., Buchner H., Gouzoulis-Mayfrank E. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 2000, 22:608-617.
84. Tye N.C., Everitt B.J., Iversen S.D. 5-Hydroxytryptamine and punishment. Nature 1977, 268:741-743.
85. Verdejo-Garcia A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 2008, 32:777-810.
86. Vollenweider F.X., Gamma A., et al. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naive healthy volunteers. Neuropsychopharmacology 1998, 19(4):241-251.
87. von Geusau N.A., Stalenhoef P., Huizinga M., Snel J., Ridderinkhof K.R. Impaired executive function in male MDMA ("ecstasy") users. Psychopharmacology (Berl) 2004, 175:331-341.
88. Wilson M.A., Ricaurte G.A., Molliver M.E. Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3, 4-methylenedioxymethamphetamine. Neuroscience 1989, 28:121-137.
89. Wingrove J., Bond A.J. Impulsivity: a state as well as trait variable. Does mood awareness explain low correlations between trait and behavioural measures of impulsivity?. Pers. Individ. Differ. 1998, 333-339.